8-PIP-cAMP structure
|
Common Name | 8-PIP-cAMP | ||
---|---|---|---|---|
CAS Number | 31357-06-9 | Molecular Weight | 434.31900 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C15H20N6NaO6P | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A |
Name | sodium,(4aR,6R,7R,7aS)-6-(6-amino-8-piperidin-1-ylpurin-9-yl)-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol |
---|---|
Synonym | More Synonyms |
Molecular Formula | C15H20N6NaO6P |
---|---|
Molecular Weight | 434.31900 |
Exact Mass | 434.10800 |
PSA | 170.72000 |
LogP | 1.25730 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis.
Cell Death Dis. 4 , e516, (2013) We show that cyclic AMP (cAMP) elevating agents protect blasts from patients with acute promyelocytic leukemia (APL) against death induced by first-line anti-leukemic anthracyclines like daunorubicin ... |
|
8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms.
PLoS ONE 6(6) , e20785, (2011) Cyclic AMP (cAMP) inhibits the proliferation of several tumor cells. We previously reported an antiproliferative effect of PKA I-selective cAMP analogs (8-PIP-cAMP and 8-HA-cAMP) on two human cancer c... |
8-Piperidinoadenosine 3',5'-monophosphate sodium salt |
8-PIP-cAMP |
8-Piperidinoadenosine 3 inverted exclamation marka,5 inverted exclamation marka-monophosphate sodium salt |
8-Piperidinoadenosine 3',5'-monophosphate |
8-Piperidino-cyclicAMP |
Cyclic 8-piperidino-3',5'-AMP |